Are Cancer Patients Getting Treated in Time?

Cancer is the second most common cause of death in the UK. Some 376,000 new cases are diagnosed each year and 167,000 people die from the disease — one in two people born after 1960 will receive a cancer diagnosis in their lifetime.^[1] The NHS Long-Term Plan committed to diagnosing 75% of cancers at stage 1 or 2 by 2028, yet the current figure sits at around 54%, well behind Denmark and Sweden where 60–65% are caught early.^[3] Late-stage diagnosis is the primary driver of the UK's survival gap: five-year bowel cancer survival is 57% here against 67% in Australia; ovarian cancer survival is 35% compared with 45%.^[4] Deprivation is the strongest predictor of late presentation — patients in the least deprived quintile are 30% more likely to be diagnosed at stage 1.^[1]

The 62-day urgent referral-to-treatment standard has not been met since 2015. By 2023 the compliance rate had fallen to 67.4% against an 85% target, while 16,200 patients were waiting more than 104 days for treatment to begin.^[2] COVID-19 inflicted catastrophic disruption: an estimated 350,000 fewer cancers were diagnosed in 2020, and the resulting diagnostic backlog has never fully cleared.^[1] GP referral rates vary threefold across practices, creating a postcode lottery at the point of entry, and one-year bowel cancer survival ranges from 89% to 93% across NHS regions — a gap that reflects systemic variation in access rather than biology.^[2]